Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients

Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients

Abstract Background Gastrointestinal manifestations of coronavirus disease 2019 (COVID-19) appear to be substantial. Fecal calprotectin is a promising biomarker in COVID-19 associated gastrointestinal inflammation; however, its role in the severity of COVID-19 remains limited. We conducted a study t...

Full description

Bibliographic Details
Main Authors: Deasy Natalia Adriana, Titong Sugihartono, Iswan Abbas Nusi, Poernomo Boedi Setiawan, Herry Purbayu, Ummi Maimunah, Ulfa Kholili, Budi Widodo, Husin Thamrin, Amie Vidyani, Hasan Maulahela, Yoshio Yamaoka, Muhammad Miftahussurur
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Gut Pathogens
Subjects:
Fecal calprotectin
P/F ratio
COVID-19
Infectious disease
Online Access:https://doi.org/10.1186/s13099-022-00507-y

Internet

https://doi.org/10.1186/s13099-022-00507-y

Similar Items